Intranasal CRMP2-Ubc9 inhibitor regulates NaV 1.7 to alleviate trigeminal neuropathic pain.
- Resource Type
- Academic Journal
- Source
PAIN (PAIN), Mar2024; 165(3): 573-588. (16p)- Subject
- Language
- English
- ISSN
- 0304-3959